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OSX-CRE DIRECTED ABLATION OF SITE-1 PROTEASE IN MICE
RESULTS IN KYPHOSIS AND SCOLIOSIS
D. Patra, L. Sandell. Washington Univ. Sch. of Med., St. Louis, MO, USA
Purpose: Site-1 protease (S1P) is a proprotein convertase that is pri-
marily known for processing of latent, endoplasmic reticulum (ER)
membrane-bound transcription factors SREBPs and ATF6 to their free
and active form. SREBPs are involved in cholesterol and fatty acid
homeostasis; ATF6 is involved in ER stress response. Cartilage-speciﬁc
ablation of S1P in mice (S1Pcko) using Col2-Cre results in poor cartilage
with a drastic decrease of collagen type IIB (Col IIB) in the matrix and a
complete lack of endochondral bone formation, even though the
molecular program for chondrocyte maturation is not disrupted. In a
postnatal model using Col2-CreERT mice, ablation of S1P in postnatal
chondrocytes gradually eliminates the primary growth plate with a
gradual abolition of Ihh and type X collagen expression in the growth
plate indicating a cessation of hypertrophic chondrocyte differentiation.
The goal of this study is to understand the importance of S1P in
chondrocyte maturation in the growth plate.
Methods: The osterix protein is expressed in prehypertrophic chon-
drocytes (as well as in osteoblasts). S1Pf/f mice (homozygous for the
S1Pﬂox allele inwhich exon 2 of S1P is ﬂoxed) were crossed with Osx-Cre
mice (inwhich the Cre recombinase is under the inﬂuence of the Osterix
(Osx) promoter) to obtain mice with S1P ablation in prehypertrophic
chondrocytes (S1POsx mice). S1POsx mice and wild type littermates were
studied by histology, immunoﬂuorescence (IF), and micro-computed
tomography (mCT) techniques.
Results:Mice with a homozygous deletion for S1P (S1Pf/f;Osx-Cre mice
or S1Pcko-Osx) suffer from severe chondrodysplasia that is visible in their
gross morphology beginning from postnatal day 7. Mice which are
heterozygous for S1P deletion (S1Pþ/f-Osx) have a size intermediate to
the S1Pcko-Osx mice and their wild type littermates; additionally, these
mice are also hunchbacks (kyphosis) which gets more pronounced with
age. Interestingly, mCT analysis not only conﬁrmed the kyphosis in S1Pþ/
f-Osx mice, but also revealed scoliosis in the S1Pcko-Osx mice. Micro-CT
analysis also showed decreased bone mineralization in both mutant
mice with the S1Pcko-Osx mice showing a more drastic decrease than the
heterozygote resulting in fragile bones. In embryonic studies, S1Pcko-Osx
mice exhibited a delay in the onset for endochondral bone formation,
while the S1Pþ/f-Osx showed normal onset of endochondral bone for-
mation as the wild type. In immunoﬂuorescence studies for type II
collagen (Col II) distribution, while the Col2-Cre-directed S1Pcko mice
exhibited Col II entrapment in all zones of the growth plate including
the resting and proliferative zone, S1Pcko-Osx mice showed Col II
entrapment only in the hypertrophic zone, but not the resting and
proliferative zones; negligible Col II entrapment was observed in the
growth plate of S1Pþ/f-Osx mice.
Conclusions: These results indicate the indispensable nature of S1P for
cartilage and overall skeletal development. S1P is essential for normal
growth plate activity and cartilage formation. The current study also
endorses the importance of S1P in normal skeletal development and is
important for both axial and appendicular skeletal development. For
the ﬁrst time, we demonstrate an important functional link between
S1P and diseases of the vertebral column. These studies also suggest an
indispensable role for S1P in osteoblasts. Thus understanding the con-
tributions of S1P in cartilage, bone and vertebrae development will
contribute to the understanding of overall skeletal homeostasis.
96
SOX9 DIRECTLY REGULATES CTGF/CCN2 TRANSCRIPTION IN GROWTH
PLATE CHONDROCYTES AND IN NUCLEUS PULPOSUS CELLS OF
INTERVERTEBRAL DISC
C. Oh y, H. Yasuda z, S. Henry z, Z. Zhang z, M. Xue y,
B. de Crombrugghe z, D. Chen y. yRush Univ. Med. Ctr., Chicago, IL, USA;
z The Univ. of Texas, M.D. Anderson Cancer Ctr., Houston, TX, USA
Purpose: Several lines of evidence demonstrated that connective tissue
growth factor (CTGF/CCN2) stimulates chondrocyte proliferation and
maturation and is required for cartilage development. Since SOX9 is a
key transcription factor controlling several steps of the chondrocyte
differentiation pathway, in the present studies, we have determined
whether SOX9 directly regulates Ctgf (Ccn2) expression in chondrocytes
Methods: Primary sternal chondrocytes derived from Sox9 ﬂox/ﬂox mice
were infected with Cre recombinase-expressing adenovirus (Ad-CMV-Cre). We performed ChIP-on-chip assay using anti-SOX9 antibody,
covering the Ctgf gene from 15 kb upstream of its 5’-end to 10 kb
downstream of its 3’-end to identify SOX9 interaction site. The SOX9
binding site was then veriﬁed by the Ctgf reporter assays, electro-
phoretic mobility shift assay and the ChIP-qPCR assay. In addition, we
also generated chondrocyte-speciﬁc Sox9 knockout (KO)mice to further
determine the role of SOX9 in regulation of Ctgf in vivo
Results:We found that expression of CtgfmRNA and proteinwas down-
regulated in primary sternal chondrocytes from Sox9 ﬂox/ﬂox mice
infected with Ad-CMV-Cre. One high-afﬁnity interaction site was
identiﬁed in the Ctgf proximal promoter by ChIP-on-chip assay which is
located in -70/-64 region of the Ctgf promoter. We found the same SOX9
binding site in the Ctgf promoter in nucleus pulposus (NP) cells. The
function of this binding site was determined by a serious of reporter
assays, an electrophoretic mobility shift assay and a ChIP-qPCR assay.
Deletion of Sox9 in growth plate and articular chondrocytes in long
bone or in NP cells in intervertebral disc tissue signiﬁcantly down-
regulated CTGF expression in 2-month-old Sox9 KO mice
Conclusions: Our studies suggest that Ctgf is a direct target of SOX9 in
growth plate chondrocytes and in NP cells in disc tissues. CTGF
expression is regulated by SOX9 during chondrogenesis and homeo-
stasis of disc tissue in adult mice. Our ﬁndings establish a strong link
between two regulatory molecules that have a major role in cartilage
and disc tissue
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BAPX1/NKX3.2; A NOVEL CHONDROCYTE HYPERTROPHY
MOLECULAR SWITCH IN OSTEOARTHRITIS
M.M. Caron y, P.J. Emans y, D.A. Surtel y, P.M. van der Kraan z,
L.W. van Rhijn y, T.J. Welting y. yMaastricht Univ. Med. Ctr., Maastricht,
Netherlands; zRadboud Univ. Med. Ctr., Nijmegen, Netherlands
Purpose: Osteoarthritis (OA) is the most common degenerative joint
disorder and presents with degradation of articular cartilage, leading to
loss of joint mobility and function, accompanied by chronic pain.
Recently we showed that Bone Morphogenetic Protein 7 (BMP-7) is able
to suppress chondrocyte hypertrophic differentiation from progenitor
cells and that the transcriptional repressor Bapx1/Nkx3.2 plays a key
role in this action. As OA involves a shift of the articular chondrocyte
phenotype towards hypertrophic differentiation andmineralization, we
hypothesized that impaired Bapx1/Nkx3.2 function and concomitant
loss of hypertrophic protection of the articular chondrocyte is central in
the changing chondrocyte phenotype that drives OA.
Methods: Healthy and OA human articular chondrocytes (HACs) were
isolated from healthy knee cartilage or from OA cartilage from total
knee arthroplasty. HACs were exposed to BMP-7, IL-1b, TNFa or OA
synovial ﬂuid. Loss- and gain-of-function experiments were performed
using siRNA duplexes targeting Bapx1/Nkx3.2 and by transiently over-
expressing FLAG-Bapx1/Nkx3.2 by transfection of cloned vectors.
Mouse experimental models for OAwere used (DMM- and collagenase-
induced OA) and (immuno)histochemistry was applied on knee joint
tissue sections. Gene- and protein expression of Bapx1/Nkx3.2 and
important chondrogenic-, hypertrophic-, cartilage degrading- and
inﬂammatory mediators were determined by RT-qPCR and immuno-
blotting. ALP activity was determined using a colorimetric assay and
PGE2 levels were measured by EIA.
Results: Exposure of healthy HACs to BMP-7 lead to a pronounced
increased expression of Sox9, Col2a1 and Acan expression. At the same
time, expression of hypertrophy associated genes Runx2, Col10a1 and
ALP was suppressed, suggesting the existence of a general pro-chon-
drogenic and hypertrophy-suppressive action of BMP-7. Interestingly,
BMP-7 signiﬁcantly increased Bapx1/Nkx3.2 mRNA levels. Knocking-
down Bapx1/Nkx3.2 in healthy HACs did not signiﬁcantly inﬂuence the
expression levels of chondrogenic genes, but led to a major hyper-
trophic shift in the HAC phenotype. Overexpression of FLAG-Bapx1/
Nkx3.2 again did not change expression levels of Sox9, Col2a1 and Acan.
However, it decreased the expression of Runx2, Col10a1 and ALP in
healthy HACs suggesting that Bapx1/Nkx3.2 fulﬁlls a central regulating
role in balancing the chondrocyte phenotype with speciﬁc regulatory
functions in controlling the chondrocytes’ hypertrophic phenotype.
In OA(-induced) chondrocytes, Bapx1/Nkx3.2 expression negatively
correlated with expression of chondrocyte hypertrophic markers, car-
tilage degrading enzymes (MMP13, ADAMTS5) and inﬂammatory
mediators (COX-2, IL-6). Furthermore, Bapx1/Nkx3.2 positivity was
diminished in articular chondrocytes in knee joints from mouse
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acted by overexpression of FLAG-Bapx1/Nkx3.2 and by BMP-7 in a
Bapx1/Nkx3.2 dependent manner. In addition, we mimicked an OA
inﬂammatory environment by exposing healthy HACs to OA synovial
ﬂuid (SF) and in agreement with its katabolic properties, SF exposure
lead to decreased Bapx1/Nkx3.2 expression and overexpression of
FLAG-Bapx1/Nkx3.2 protected the HACs against the effects of SF
exposure. Together these data show that overexpression of Bapx1/
Nkx3.2 in OA HACs and in healthy HACs exposed to an OA synovial ﬂuid
environment is able to change the OA-associated chondrocyte hyper-
trophic phenotype to a more chondrogenic phenotype and counteract
the expression of important OA related katabolic genes.
Conclusions: We show that Bapx1/Nkx3.2 is an important, yet unrec-
ognized, molecular switch that is centrally involved in controlling the
hypertrophic phenotype of the post-developmental articular chon-
drocyte. Our data suggest that due to the OA environment functional
Bapx1/Nkx3.2 levels drop in OA chondrocytes, leading to destabilization
of the Sox9-Runx2 balance and causing a phenotypic shift towards a
hypertrophic and katabolic differentiation state. Although central in the
development of OA, there is a lack of treatment options that address the
chondrocyte phenotype and important effort is needed to identify tar-
getable pathways or individual factors that alter the chondrocyte’s
phenotype in OA. We expect that Bapx1/Nkx3.2 provides an interesting
candidate to pursue such an approach.
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ALLOGENEIC MESENCHYMAL STEM CELLS IMPROVE INDICES OF
LUMBAR INTERVERTEBRAL DISC DEGENERATION WITHOUT SITE
SPECIFICITY OF INJECTION IN AN OVINE MODEL
B. Freeman y,z, J. Kuliwaba x,z, M. Zarrinkalam x,z, C. Jones x,z, C. Shu k,
C. Colloca ¶, J. Melrose k, A. Mulaibrahimovic x, S. Gronthos#,yy,
A. Zannettino#,yy, S. Howell zz. yDept. of Spinal Surgery, Royal Adelaide
Hosp., Adelaide, Australia; zCtr. for Orthopaedic & Trauma Res., The Univ.
of Adelaide, Adelaide, Australia; xAdelaide Ctr. for Spinal Res., SA
Pathology, Adelaide, Australia; kKolling Inst. of Med. Res., Univ. of
Sydney, Sydney, Australia; ¶Coll. of Hlth.Solutions, Arizona State Univ.,
Phoenix, AZ, USA; # Sch. of Med. Sci., The Univ. of Adelaide, Adelaide,
Australia; yy South Australian Hlth.and Med. Res. Inst., Adelaide,
Australia; zzData Management and Analysis Ctr., The Univ. of Adelaide,
Adelaide, Australia
Purpose: Low back pain (LBP) is the most common musculoskeletal
condition affecting an individual’s ability to work and manage activ-
ities of daily living. Degenerative intervertebral disc (IVD) disease is
one of the most common causes of LBP with up to 10% of these indi-
viduals developing chronic disability. Spinal fusion for chronic dis-
cogenic LBP is invasive, has mixed long-term results, and appears to
have little value over conservative measures such as physiotherapy and
rehabilitation. There is increasing interest in cell therapy for degen-
erative IVD disease that aims to repair and regenerate the IVD.Previous studies assessing the efﬁcacy of stem cell injection into
degenerated IVDs have reported positive ﬁndings. However studies
have been predominantly limited to small animals, targeting the
nucleus pulposus (NP), with short term follow-up. The purpose of this
study was to utilize an in vivo ovine model of IVD degeneration to
determine if allogeneic mesenchymal stem cells (MSCs) delivered to
the NP or the annulus ﬁbrosus (AF) of degenerated lumbar IVDs leads
to improved indices of disc health.
Methods: Bone marrow aspirates were obtained from the iliac crest of
8-week-old sheep. MSCs were isolated and then culture expanded for 4
passages. IVD degeneration was induced by a precise postero-lateral
annulotomy at three lumbar levels in eight 2-year-old sheep. Six
months later, each degenerated IVD was randomized to one of three
treatments: Injection of MSC (1 million cells/0.2ml phosphate buffered
saline) into i) the previously incised AF (AFI) or ii) into the NP (NPI); or
iii) no injection (negative control, NC). The superior adjacent (normal)
IVD received an injection of phosphate buffered saline only (0.2ml) into
the NP (positive control, PC). Radiographs and magnetic resonance
image (MRI) scans were obtained at baseline, 6, 9, and 12 months to
determine disc height index (DHI), disc height (DH) and grade of disc
degeneration at each timepoint. Discs were harvested at 12 months for
biochemical (water, proteoglycan and hydroxyproline content) and
histological analysis (disc degeneration grade).
Results: IVD degenerationwas consistently observed at 6 months in the
24 discs that underwent postero-lateral annulotomy. This was charac-
terized by reduced DHI (33%, p<0.01), reduced DH (p<0.0001), and
increased grade of disc degeneration both on MRI scan and subsequent
histological analysis at 12 months (p<0.0001). These results were not
observed in the PC discs. Six months following stem cell injection; DHI
had recovered by 16% and 33% in the NPI and AFI groups respectively
(p<0.01); DH had recovered in the NPI and AFI groups by 18% and 22%
respectively (p<0.02); Mean Pﬁrrmann grade improved from 3.25 to
2.67 (-0.58) in the AFI group and from 2.96 to 2.43 (-0.53) in the NPI
group, whilst the NC group improved from 3.10 to 2.81 (-0.29). Mean
histopathological grade improved in both the NPI (p<0.02) and the AFI
(p<0.002) groups when compared to the NC group. No signiﬁcant dif-
ferences were noted in the glycosaminoglycan (GAG) or the hydrox-
yproline (HyPro) content across all four groups.
Conclusions: Intervertebral disc degeneration was reliably induced in
2-year-old sheep by the performance of a postero-lateral annulotomy
and allowing 6 months for the degeneration to occur. In this ovine
model, the injection of allogeneic MSCs into either the annulus ﬁbrosus
or the nucleus pulposus of degenerated IVD resulted in signiﬁcant
improvements over 6 months in disc health (DHI, DH and grade of disc
degeneration) when compared to control groups. Thus, improvements
in disc health appear to be independent of the site of stem cell injection
(annulus ﬁbrosus or nucleus pulposus). No measurable improvements
were observed in disc biochemistry. Further study into the efﬁcacy of
MSCwould appear to bewarranted for the treatment of established disc
degeneration.
